Page 103 - 2020_02-Haematologica-web

Irf2bp2b regulates zebrafish NMP cell fate choice
14. Childs KS, Goodbourn S. Identification of novel co-repressor molecules for interferon regulatory factor-2. Nucleic Acids Res. 2003;31(12):3016-3026.
15. Yeung KT, Das S, Zhang J, et al. A novel transcription complex that selectively mod- ulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol Cell Biol. 2011;31(11):2287-2298.
16. Stadhouders R, Cico A, Stephen T, et al. Control of developmentally primed ery- throid genes by combinatorial co-repressor actions. Nat Commun. 2015;6:8893.
17. Carneiro FR, Ramalho-Oliveira R, Mognol GP, Viola JP. Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. Mol Cell Biol. 2011;31(14):2889-2901.
18. Secca C, Faget DV, Hanschke SC, et al. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering. J Leukoc Biol. 2016;100(5):1081-1091.
19. Chen HH, Keyhanian K, Zhou X, et al. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis. Circ Res. 2015;117(8):671-683.
20. Yin CC, Jain N, Mehrotra M, et al. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw. 2015;13(1):19-22.
21. Shimomura Y, Mitsui H, Yamashita Y, et al. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion. Cancer Sci. 2016;107(8):1165-1168.
22. Jovanovic JV, Chillon MC, Vincent-Fabert C, et al. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia. Leukemia. 2017;31(3):747-751.
23. Mazharuddin S, Chattopadhyay A, Levy MY, Redner RL. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid. Leuk Lymphoma. 2018;59(9):2246-2249.
24. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryon- ic development of the zebrafish. Dev Dyn. 1995;203(3):253-310.
25. Thisse C, Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 2008;3(1):59-69.
26. Teng AC, Kuraitis D, Deeke SA, et al. IRF2BP2 is a skeletal and cardiac muscle- enriched ischemia-inducible activator of VEGFA expression. FASEB J. 2010;24(12): 4825-4834.
27. Gore AV, Pillay LM, Venero Galanternik M,
Weinstein BM. The zebrafish: a fintastic Biochim Biophys Acta. 2009;1789(6-8):451- model for hematopoietic development and 459.
disease. Wiley Interdiscip Rev Dev Biol. 40. Rodriguez MS, Dargemont C, Hay RT. 2018;7(3):e312. SUMO-1 conjugation in vivo requires both a
28. Teng AC, Al-Montashiri NA, Cheng BL, et consensus modification motif and nuclear al. Identification of a phosphorylation- targeting. J Biol Chem. 2001;276(16):12654- dependent nuclear localization motif in 12659.
interferon regulatory factor 2 binding pro- 41. Weston BR, Li L, Tyson JJ. Mathematical tein 2. PloS One. 2011;6(8):e24100. analysis of cytokine-induced differentiation
29. Lekstrom-Himes J, Xanthopoulos KG. of granulocyte-monocyte progenitor cells. CCAAT/enhancer binding protein epsilon is Front Immunol. 2018;9:2048.
critical for effective neutrophil-mediated 42. Kummalue T, Friedman AD. Cross-talk response to inflammatory challenge. Blood. between regulators of myeloid develop- 1999;93(9):3096-3105. ment: C/EBPalpha binds and activates the
30. Meijer AH, van der Sar AM, Cunha C, et al. promoter of the PU.1 gene. J Leukoc Biol. Identification and real-time imaging of a 2003;74(3):464-470.
myc-expressing neutrophil population 43. Yeamans C, Wang D, Paz-Priel I, Torbett BE, involved in inflammation and mycobacterial Tenen DG, Friedman AD. C/EBPalpha binds granuloma formation in zebrafish. Dev and activates the PU.1 distal enhancer to Comp Immunol. 2008;32(1):36-49. induce monocyte lineage commitment.
31. Zakrzewska A, Cui C, Stockhammer OW, Blood. 2007;110(9):3136-3142.
Benard EL, Spaink HP, Meijer AH. 44. Lidonnici MR, Audia A, Soliera AR, et al. Macrophage-specific gene functions in Spi1- Expression of the transcriptional repressor directed innate immunity. Blood. 2010;116 Gfi-1 is regulated by C/EBPα and is involved (3):e1-11. in its proliferation and colony formation-
32. Spilsbury K, O'Mara MA, Wu WM, Rowe inhibitory effects in p210BCR/ABL-express- PB, Symonds G, Takayama Y. Isolation of a ing cells. Cancer Res. 2010;70(20): 7949- novel macrophage-specific gene by differen- 7959.
tial cDNA analysis. Blood. 1995;85(6):1620- 45. Reddy VA, Iwama A, Iotzova G, et al. 1629. Granulocyte inducer C/EBPalpha inactivates
33. Le Guyader D, Redd MJ, Colucci-Guyon E, the myeloid master regulator PU.1: possible et al. Origins and unconventional behavior role in lineage commitment decisions. of neutrophils in developing zebrafish. Blood. 2002;100(2):483-490.
Blood. 2008;111(1):132-141. 46. Dahl R, Iyer SR, Owens KS, Cuylear DD,
34. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu Simon MC. The transcriptional repressor L. Dynamic regulation of PU.1 expression in GFI-1 antagonizes PU.1 activity through multipotent hematopoietic progenitors. J protein-protein interaction. J Biol Chem. Exp Med. 2005;201(2):221-231. 2007;282(9):6473-6483.
35. Avellino R, Delwel R. Expression and regu- 47. Trainor CD, Omichinski JG, Vandergon TL, lation of C/EBPα in normal myelopoiesis Gronenborn AM, Clore GM, Felsenfeld G. A and in malignant transformation. Blood. palindromic regulatory site within verte- 2017;129(15):2083-2091. brate GATA-1 promoters requires both zinc
36. Vonderfecht TR, Schroyer DC, Schenck BL, fingers of the GATA-1 DNA-binding McDonough VM, Pikaart MJ. Substitution domain for high-affinity interaction. Mol of DNA-contacting amino acids with func- Cell Biol. 1996;16(5):2238-2247.
tional variants in the Gata-1 zinc finger: a 48. de The H, Vivanco-Ruiz MM, Tiollais P, structurally and phylogenetically guided Stunnenberg H, Dejean A. Identification of a mutagenesis. Biochem Biophys Res retinoic acid responsive element in the Commun. 2008;369(4):1052-1056. retinoic acid receptor beta gene. Nature.
37. Urnov FD. A feel for the template: zinc fin- 1990;343(6254):177-180.
ger protein transcription factors and chro- 49. de The H, Pandolfi PP, Chen Z. Acute matin. Biochem Cell Biol. 2002;80(3):321- promyelocytic leukemia: a paradigm for 333. oncoprotein-targeted cure. Cancer Cell.
38. Han ZJ, Feng YH, Gu BH, Li YM, Chen H. 2017;32(5):552-560.
The post-translational modification, 50. Zhou J, Peres L, Honore N, Nasr R, Zhu J, de SUMOylation, and cancer. Int J Oncol. The H. Dimerization-induced corepressor 2018;52(4):1081-1094. binding and relaxed DNA-binding specifici-
39. Garcia-Dominguez M, Reyes JC. SUMO ty are critical for PML/RARA-induced association with repressor complexes, immortalization. Proc Nal Acad Sci U S A. emerging routes for transcriptional control. 2006;103(24):9238-9243.
haematologica | 2020; 105(2)
337